Day’s Recap is unavailable for this topic and date. Feel free to go through our curated list of stories below.
Other Developments
A curated list of other prominent stories from this day.
8:03 PMTechCrunch
Meta reportedly moves to unwind $2B Manus deal after Beijing’s demand
Summary
Meta is reportedly beginning to unwind its $2 billion acquisition of Manus after Chinese authorities ordered the transaction reversed. The company is said to be taking steps to dismantle the deal structure rather than proceeding toward closing.
Why it matters
Regulators are increasingly dictating M&A outcomes after announcement, raising the probability that geopolitics, not price, determines whether deals survive.
Luke Miels, the quiet GSK boss making a $10.6bn bet on cancer
Summary
GSK agreed to buy a biotech company for $10.6bn, its largest biotech acquisition in more than 25 years. The deal is positioned as a major push to expand GSK's cancer portfolio and future growth drivers.
Why it matters
A $10.6bn oncology acquisition resets expectations for GSK's growth plan and can tighten the M&A market for cancer assets across pharma.